Washington: Scientists have used a new approach to identify compounds with the potential to delay or treat Alzheimer`s disease, and possibly Parkinson`s, Lou Gehrig`s disease and other degenerative disorders. All of these diseases are marked by harmful, elongated, rope-like structures known as amyloid fibrils, linked protein molecules that form in the brains of patients. The new structure-based approach to drug design, in which the physical structure of a targeted protein is used to help identify compounds that will interact with it, has already been used to generate therapeutic agents for a number of infectious and metabolic diseases.
Pune blast: ATS tracking online chats of IM terrorists
Devotees throng Mathura on the occassion of Guru Purnima
Shirdi Sai Baba is not God or Guru, says Shankaracharya
UPSC aspirants protest outside Rajnath Singh`s residence